Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal
Page 41, Column 1, Section 3.1, paragraph 2, 1st sentence which
Gespeichert in:
| Veröffentlicht in: | PharmacoEconomics 2018-04, Vol.36 (4), p.507-507 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 507 |
|---|---|
| container_issue | 4 |
| container_start_page | 507 |
| container_title | PharmacoEconomics |
| container_volume | 36 |
| creator | Tikhonova, Irina A. Jones-Hughes, Tracey Dunham, James Warren, Fiona C. Robinson, Sophie Stephens, Peter Hoyle, Martin |
| description | Page 41, Column 1, Section 3.1, paragraph 2, 1st sentence which |
| doi_str_mv | 10.1007/s40273-018-0635-4 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2008367065</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A714601227</galeid><sourcerecordid>A714601227</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2514-78121d49ee407cdbb7c19fc821ee192c67b8e6611d10ecedd07b0aee828c128a3</originalsourceid><addsrcrecordid>eNp9ksFu1DAQhiMEomXhAbigkbhwSbG92TjpbbUsbaWKInY5W44z2bpy7GA72_aNeQyc3YKEhJAPtma-mflt_1n2lpIzSgj_GArC-DwntMpJOV_kxbPslFJe5yzFnx_OJOdlTU6yVyHcEZIozl5mJ6wueEXp4jT7uXLeo4raWYjuHG6M9DKOvWxAW1i5vtFWHrL3Ot7CJ_fg_NholZKd8xBvEbYeZezRRnAdLNu9tApb2LguwlaHMCJspFeul-ewtLDe6xYTAd9wr_EeLrwbB_iKPgyTjD1OXSR8OQyVBq5siDqOEQ_zLlGaJEPaFlZGW60SsX5QaMyh50bbnUmKUN1aZ9zuEZbD4KUO0rzOXnTSBHzztM-y75_X29Vlfn1zcbVaXueKLWiRp2dhtC1qxIJw1TYNV7TuVMUoIq2ZKnlTYVlS2lKC6Z4t4Q2RiBWrFGWVnM-yD8e-g3c_RgxR9DpMAqVFNwbBCKnmJSflIqHvj-hOGhTadi56qSZcLDktSkJZ-t5ZdvYPKq0We62cxU6n-F8F9FigvAvBYycGr3vpHwUlYvKNOPpGJN-IyTeiSDXvnlSPTY_tn4rfRkkAOwIhpewOvbhzo08fFP7T9ReNItDi</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2008367065</pqid></control><display><type>article</type><title>Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal</title><source>SpringerNature Journals</source><creator>Tikhonova, Irina A. ; Jones-Hughes, Tracey ; Dunham, James ; Warren, Fiona C. ; Robinson, Sophie ; Stephens, Peter ; Hoyle, Martin</creator><creatorcontrib>Tikhonova, Irina A. ; Jones-Hughes, Tracey ; Dunham, James ; Warren, Fiona C. ; Robinson, Sophie ; Stephens, Peter ; Hoyle, Martin</creatorcontrib><description>Page 41, Column 1, Section 3.1, paragraph 2, 1st sentence which</description><identifier>ISSN: 1170-7690</identifier><identifier>EISSN: 1179-2027</identifier><identifier>DOI: 10.1007/s40273-018-0635-4</identifier><identifier>PMID: 29478115</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Correction ; Health Administration ; Health Economics ; Medicine ; Medicine & Public Health ; Pharmacoeconomics and Health Outcomes ; Public Health ; Quality of Life Research</subject><ispartof>PharmacoEconomics, 2018-04, Vol.36 (4), p.507-507</ispartof><rights>Springer International Publishing AG, part of Springer Nature 2018</rights><rights>COPYRIGHT 2018 Springer</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s40273-018-0635-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s40273-018-0635-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,781,785,27926,27927,41490,42559,51321</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29478115$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tikhonova, Irina A.</creatorcontrib><creatorcontrib>Jones-Hughes, Tracey</creatorcontrib><creatorcontrib>Dunham, James</creatorcontrib><creatorcontrib>Warren, Fiona C.</creatorcontrib><creatorcontrib>Robinson, Sophie</creatorcontrib><creatorcontrib>Stephens, Peter</creatorcontrib><creatorcontrib>Hoyle, Martin</creatorcontrib><title>Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal</title><title>PharmacoEconomics</title><addtitle>PharmacoEconomics</addtitle><addtitle>Pharmacoeconomics</addtitle><description>Page 41, Column 1, Section 3.1, paragraph 2, 1st sentence which</description><subject>Correction</subject><subject>Health Administration</subject><subject>Health Economics</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Pharmacoeconomics and Health Outcomes</subject><subject>Public Health</subject><subject>Quality of Life Research</subject><issn>1170-7690</issn><issn>1179-2027</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9ksFu1DAQhiMEomXhAbigkbhwSbG92TjpbbUsbaWKInY5W44z2bpy7GA72_aNeQyc3YKEhJAPtma-mflt_1n2lpIzSgj_GArC-DwntMpJOV_kxbPslFJe5yzFnx_OJOdlTU6yVyHcEZIozl5mJ6wueEXp4jT7uXLeo4raWYjuHG6M9DKOvWxAW1i5vtFWHrL3Ot7CJ_fg_NholZKd8xBvEbYeZezRRnAdLNu9tApb2LguwlaHMCJspFeul-ewtLDe6xYTAd9wr_EeLrwbB_iKPgyTjD1OXSR8OQyVBq5siDqOEQ_zLlGaJEPaFlZGW60SsX5QaMyh50bbnUmKUN1aZ9zuEZbD4KUO0rzOXnTSBHzztM-y75_X29Vlfn1zcbVaXueKLWiRp2dhtC1qxIJw1TYNV7TuVMUoIq2ZKnlTYVlS2lKC6Z4t4Q2RiBWrFGWVnM-yD8e-g3c_RgxR9DpMAqVFNwbBCKnmJSflIqHvj-hOGhTadi56qSZcLDktSkJZ-t5ZdvYPKq0We62cxU6n-F8F9FigvAvBYycGr3vpHwUlYvKNOPpGJN-IyTeiSDXvnlSPTY_tn4rfRkkAOwIhpewOvbhzo08fFP7T9ReNItDi</recordid><startdate>201804</startdate><enddate>201804</enddate><creator>Tikhonova, Irina A.</creator><creator>Jones-Hughes, Tracey</creator><creator>Dunham, James</creator><creator>Warren, Fiona C.</creator><creator>Robinson, Sophie</creator><creator>Stephens, Peter</creator><creator>Hoyle, Martin</creator><general>Springer International Publishing</general><general>Springer</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201804</creationdate><title>Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal</title><author>Tikhonova, Irina A. ; Jones-Hughes, Tracey ; Dunham, James ; Warren, Fiona C. ; Robinson, Sophie ; Stephens, Peter ; Hoyle, Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2514-78121d49ee407cdbb7c19fc821ee192c67b8e6611d10ecedd07b0aee828c128a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Correction</topic><topic>Health Administration</topic><topic>Health Economics</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Pharmacoeconomics and Health Outcomes</topic><topic>Public Health</topic><topic>Quality of Life Research</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tikhonova, Irina A.</creatorcontrib><creatorcontrib>Jones-Hughes, Tracey</creatorcontrib><creatorcontrib>Dunham, James</creatorcontrib><creatorcontrib>Warren, Fiona C.</creatorcontrib><creatorcontrib>Robinson, Sophie</creatorcontrib><creatorcontrib>Stephens, Peter</creatorcontrib><creatorcontrib>Hoyle, Martin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>PharmacoEconomics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tikhonova, Irina A.</au><au>Jones-Hughes, Tracey</au><au>Dunham, James</au><au>Warren, Fiona C.</au><au>Robinson, Sophie</au><au>Stephens, Peter</au><au>Hoyle, Martin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal</atitle><jtitle>PharmacoEconomics</jtitle><stitle>PharmacoEconomics</stitle><addtitle>Pharmacoeconomics</addtitle><date>2018-04</date><risdate>2018</risdate><volume>36</volume><issue>4</issue><spage>507</spage><epage>507</epage><pages>507-507</pages><issn>1170-7690</issn><eissn>1179-2027</eissn><abstract>Page 41, Column 1, Section 3.1, paragraph 2, 1st sentence which</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>29478115</pmid><doi>10.1007/s40273-018-0635-4</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1170-7690 |
| ispartof | PharmacoEconomics, 2018-04, Vol.36 (4), p.507-507 |
| issn | 1170-7690 1179-2027 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2008367065 |
| source | SpringerNature Journals |
| subjects | Correction Health Administration Health Economics Medicine Medicine & Public Health Pharmacoeconomics and Health Outcomes Public Health Quality of Life Research |
| title | Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T21%3A47%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correction%20to:%20Olaratumab%20in%20Combination%20with%20Doxorubicin%20for%20the%20Treatment%20of%20Advanced%20Soft%20Tissue%20Sarcoma:%20An%20Evidence%20Review%20Group%20Perspective%20of%20a%20National%20Institute%20for%20Health%20and%20Clinical%20Excellence%20Single%20Technology%20Appraisal&rft.jtitle=PharmacoEconomics&rft.au=Tikhonova,%20Irina%20A.&rft.date=2018-04&rft.volume=36&rft.issue=4&rft.spage=507&rft.epage=507&rft.pages=507-507&rft.issn=1170-7690&rft.eissn=1179-2027&rft_id=info:doi/10.1007/s40273-018-0635-4&rft_dat=%3Cgale_proqu%3EA714601227%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2008367065&rft_id=info:pmid/29478115&rft_galeid=A714601227&rfr_iscdi=true |